|
1
|
Linkermann A, Hackl MJ, Kunzendorf U,
Walczak H, Krautwald S and Jevnikar AM: Necroptosis in immunity and
ischemia-reperfusion injury. Am J Transplant. 13:2797–2804. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee RC, Feinbaum RL and Ambros V: The
C. elegans heterochronic gene lin-4 encodes small RNAs with
antisense complementarity to lin-14. Cell. 75:843–854. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Callegari E, Elamin BK, Sabbioni S,
Gramantieri L and Negrini M: Role of microRNAs in hepatocellular
carcinoma: A clinical perspective. Onco Targets Ther. 6:1167–1178.
2013.PubMed/NCBI
|
|
6
|
Smits M, Nilsson J, Mir SE, van der Stoop
PM, Hulleman E, Niers JM, de Witt Hamer PC, Marquez VE, Cloos J,
Krichevsky AM, et al: miR-101 is down-regulated in glioblastoma
resulting in EZH2-induced proliferation, migration and
angiogenesis. Oncotarget. 1:710–720. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Malizia AP and Wang DZ: MicroRNAs in
cardiomyocyte development. Wiley Interdiscip Rev Syst Biol Med.
3:183–190. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mosakhani N, Guled M, Lahti L, Borze I,
Forsman M, Pääkkönen V, Ryhänen J and Knuutila S: Unique microRNA
profile in Dupuytren's contracture supports deregulation of
β-catenin pathway. Mod Pathol. 23:1544–1552. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He S, Liu P, Jian Z, Li J, Zhu Y, Feng Z
and Xiao Y: miR-138 protects cardiomyocytes from hypoxia-induced
apoptosis via MLK3/JNK/c-jun pathway. Biochem Biophys Res Commun.
441:763–769. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li S, Ran Y, Zhang D, Chen J, Li S and Zhu
D: MicroRNA-138 plays a role in hypoxic pulmonary vascular
remodelling by targeting Mst1. Biochem J. 452:281–291. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Morton SU, Scherz PJ, Cordes KR, Ivey KN,
Stainier DY and Srivastava D: microRNA-138 modulates cardiac
patterning during embryonic development. Proc Natl Acad Sci USA.
105:17830–17835. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu TS, Yang JJ, Yu FY and Liu BH:
Cardiotoxicity of mycotoxin citrinin and involvement of
microRNA-138 in zebrafish embryos. Toxicol Sci. 136:402–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rathore KI, Berard JL, Redensek A, Chierzi
S, Lopez-Vales R, Santos M, Akira S and David S: Lipocalin 2 plays
an immunomodulatory role and has detrimental effects after spinal
cord injury. J Neurosci. 31:13412–13419. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chia WJ, Dawe GS and Ong WY: Expression
and localization of the iron-siderophore binding protein lipocalin
2 in the normal rat brain and after kainate-induced excitotoxicity.
Neurochem Int. 59:591–599. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aigner F, Maier HT, Schwelberger HG,
Wallnöfer EA, Amberger A, Obrist P, Berger T, Mak TW, Maglione M,
Margreiter R, et al: Lipocalin-2 regulates the inflammatory
response during ischemia and reperfusion of the transplanted heart.
Am J Transplant. 7:779–788. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Parikh CR, Jani A, Mishra J, Ma Q, Kelly
C, Barasch J, Edelstein CL and Devarajan P: Urine NGAL and IL-18
are predictive biomarkers for delayed graft function following
kidney transplantation. Am J Transplant. 6:1639–1645. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng L, Xing H, Mao X, Li L, Li X and Li
Q: Lipocalin-2 promotes m1 macrophages polarization in a mouse
cardiac ischaemia-reperfusion injury model. Scand J Immunol.
81:31–38. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen Z, Wen L, Martin M, Hsu CY, Fang L,
Lin FM, Lin TY, Geary MJ, Geary GG, Zhao Y, et al: Oxidative stress
activates endothelial innate immunity via sterol regulatory element
binding protein 2 (SREBP2) transactivation of microRNA-92a.
Circulation. 131:805–814. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pontrelli P, Accetturo M and Gesualdo L:
miRNome analysis using real-time PCR. Methods Mol Biol.
1186:201–232. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ling H, Fabbri M and Calin GA: MicroRNAs
and other non-coding RNAs as targets for anticancer drug
development. Nat Rev Drug Discov. 12:847–865. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vasudevan S, Tong Y and Steitz JA:
Switching from repression to activation: microRNAs can up-regulate
translation. Science. 318:1931–1934. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
de Posse Chaves EI: Sphingolipids in
apoptosis, survival and regeneration in the nervous system. Biochim
Biophys Acta. 1758:1995–2015. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tay Y, Zhang J, Thomson AM, Lim B and
Rigoutsos I: MicroRNAs to Nanog, Oct4 and Sox2 coding regions
modulate embryonic stem cell differentiation. Nature.
455:1124–1128. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lytle JR, Yario TA and Steitz JA: Target
mRNAs are repressed as efficiently by microRNA-binding sites in the
5′ UTR as in the 3′ UTR. Proc Natl Acad Sci USA. 104:9667–9672.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Knoll M, Lodish HF and Sun L: Long
non-coding RNAs as regulators of the endocrine system. Nat Rev
Endocrinol. 11:151–160. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
